Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Immunol. 2007 May;28(5):219-26. Epub 2007 Apr 2.

Mesenchymal stem cells: a new strategy for immunosuppression?

Author information

1
Department of Neurosciences, Ophthalmology and Genetics, University of Genova, Genova, Italy.

Abstract

In vitro-generated mesenchymal stem cells (MSCs) initially attracted interest for their ability to undergo differentiation toward cells of different lineages. More recently, a major breakthrough was the discovery that MSCs exert a profound inhibitory effect on T cell proliferation in vitro and in vivo. Subsequently, MSCs were shown also to exert similar effects on B cells, dendritic cells and natural killer cells. These results suggested that MSCs could be used to dampen immune-mediated diseases and transplant rejection. It is possible that some of the beneficial effects of MSCs might reflect, in part, the trophic and protective activities they exert on injured cells and tissues, rather than resulting from a true transdifferentiation. In immune-mediated diseases, the protective effects might function in concert with the immunosuppressive and anti-inflammatory activities.

PMID:
17400510
DOI:
10.1016/j.it.2007.03.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center